Dashboard
Manage Tickers

RXDXPrometheus Biosciences, Inc.

Nasdaq prometheusbiosciences.com


$ 199.93 $ 0.18 (0.09 %)    

Thursday, 15-Jun-2023 15:59:37 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 435.98 $ 8.58 (2.01 %)
DIA $ 386.87 $ 4.54 (1.19 %)
SPY $ 511.25 $ 6.26 (1.24 %)
TLT $ 89.88 $ 0.90 (1.01 %)
GLD $ 212.97 $ -0.17 (-0.08 %)
$ 199.92
$ 199.68
$ 199.92 x 300
$ 199.93 x 100
$ 199.61 - $ 199.98
$ 23.27 - $ 199.98
1,860,653
na
8.12B
$ 0.00
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2023 03-31-2023 10-Q
2 02-28-2023 12-31-2022 10-K
3 11-09-2022 09-30-2022 10-Q
4 08-11-2022 06-30-2022 10-Q
5 05-12-2022 03-31-2022 10-Q
6 03-09-2022 12-31-2021 10-K
7 11-12-2021 09-30-2021 10-Q
8 08-11-2021 06-30-2021 10-Q
9 05-13-2021 03-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

ftc-files-lawsuit-to-stop-amgen-buying-horizon-therapeutics-sending-shockwaves-through-biopharma-ma
FTC Files Lawsuit To Stop Amgen Buying Hor...
05/16/2023 18:37:11

In a rare move to block a large pharma deal, the U.S.

rbc-capital-maintains-sector-perform-on-prometheus-biosciences-maintains-200-price-target
RBC Capital Maintains Sector Perform on Pr...
05/10/2023 15:34:13

RBC Capital analyst Gregory Renza maintains Prometheus Biosciences (NASDAQ:RXDX) with a Sector Perform and maintains $200 pr...

Core News & Articles
Benzinga's Top Ratings Upgrades, Downgrade...
05/10/2023 15:00:43

jefferies-downgrades-prometheus-biosciences-to-hold-raises-price-target-to-200
Jefferies Downgrades Prometheus Bioscience...
05/10/2023 09:56:34

Jefferies analyst Michael Yee downgrades Prometheus Biosciences (NASDAQ:RXDX) from Buy to Hold and raises the price target f...

here-are-the-best-performing-industry-etfs-and-major-stock-contributors-in-april
Here Are The Best-Performing Industry ETFs...
04/30/2023 14:01:31

It's a good time to look at how the major U.S. stock industry ETFs performed this month, as April comes to an end. In April...

Core News & Articles
Benzinga's Top Ratings Upgrades, Downgrade...
04/18/2023 15:00:47

wells-fargo-downgrades-prometheus-biosciences-to-equal-weight-raises-price-target-to-200
Wells Fargo Downgrades Prometheus Bioscien...
04/18/2023 10:47:31

Wells Fargo analyst Chris Carey downgrades Prometheus Biosciences (NASDAQ:RXDX) from Overweight to Equal-Weight and raises t...

credit-suisse-downgrades-prometheus-biosciences-to-neutral-raises-price-target-to-200
Credit Suisse Downgrades Prometheus Biosci...
04/18/2023 09:20:36

Credit Suisse analyst Tiago Fauth downgrades Prometheus Biosciences (NASDAQ:RXDX) from Outperform to Neutral and raises the ...

rbc-capital-downgrades-prometheus-biosciences-to-sector-perform-raises-price-target-to-200
RBC Capital Downgrades Prometheus Bioscien...
04/18/2023 09:13:32

RBC Capital analyst Gregory Renza downgrades Prometheus Biosciences (NASDAQ:RXDX) from Outperform to Sector Perform and rais...

piper-sandler-downgrades-prometheus-biosciences-to-neutral-raises-price-target-to-200
Piper Sandler Downgrades Prometheus Biosci...
04/18/2023 09:11:47

Piper Sandler analyst Yasmeen Rahimi downgrades Prometheus Biosciences (NASDAQ:RXDX) from Overweight to Neutral and raises t...

expert-ratings-for-prometheus-biosciences
Expert Ratings for Prometheus Biosciences
04/17/2023 21:01:49

crude-oil-down-2-state-street-shares-tumble-after-downbeat-results
Crude Oil Down 2%; State Street Shares Tum...
04/17/2023 18:39:46

U.S. stocks traded slightly lower toward the end of trading. The Dow traded down 0.07% to 33,862.05 while the NASDAQ fell 0.24...

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
04/17/2023 17:31:26

why-satsuma-pharmaceuticals-shares-are-trading-higher-by-94-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Satsuma Pharmaceuticals Shares Are Tra...
04/17/2023 17:27:37

Gainers ContraFect Corporation (NASDAQ: CFRX) shares surged 213% to $2.82.

nasdaq-sp-500-extend-losses-as-traders-reassess-fed-rate-path-analyst-says-dont-expect-good-news-this-earnings-season
Nasdaq, S&P 500 Extend Losses As Traders R...
04/17/2023 17:04:00

The stock market is kicking off the new week with declines on all major U.S. indices, as better-than-predicted economic prints ...

gold-drops-below-2000-charles-schwab-earnings-top-views
Gold Drops Below $2,000; Charles Schwab Ea...
04/17/2023 16:02:37

U.S. stocks traded mostly flat midway through trading, following the release of economic data. The Dow traded up 0.01% to 33,8...

Core News & Articles
Benzinga's Top Ratings Upgrades, Downgrade...
04/17/2023 15:00:43

us-stocks-mostly-flat-ny-empire-state-manufacturing-index-surges-in-april
US Stocks Mostly Flat; NY Empire State Man...
04/17/2023 14:22:57

U.S. stocks traded mostly flat this morning, following the release of economic data. Following the market opening Monday, the ...

guggenheim-downgrades-prometheus-biosciences-to-neutral-lowers-price-target-to-200
Guggenheim Downgrades Prometheus Bioscienc...
04/17/2023 13:29:23

Guggenheim analyst Yatin Suneja downgrades Prometheus Biosciences (NASDAQ:RXDX) from Buy to Neutral and lowers the price tar...

Core News & Articles
Merck CFO Says We Believe Prometheus Deal ...
04/17/2023 13:26:00

-Reuters

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION